Evidence map›Paper›PMID 21978998›Full record

ArticleAnnals of the rheumatic diseases2012

Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK.

Casimiro Castillejo-López, Angélica M Delgado-Vega, Jerome Wojcik, Sergey V Kozyrev, Elangovan Thavathiru, Ying-Yu Wu, Elena Sánchez, David Pöllmann, Juan R López-Egido, Serena Fineschi and 18 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Annals of the rheumatic diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 2 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Aberrant Enhancer Regulation, Phase Separation, and Autoimmune Diseases.Clinical reviews in allergy & immunology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. IgA Vasculitis: Influence ofJournal of clinical medicine · 2022
    Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Association ofFrontiers in genetics · 2020
    Article
  18. Review
  19. BLK and BANK1 polymorphisms and interactions are associated in Mexican patients with systemic lupus erythematosus.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 12 institutions in 7 countries.

Casimiro Castillejo-LópezCorrespondence to Marta E Alarcón-Riquelme, Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73102, USA. alarconm@omrf.org.
Angélica M Delgado-Vega
Jerome Wojcik
Sergey V Kozyrev
Elangovan Thavathiru
Ying-Yu Wu
Elena Sánchez
David Pöllmann
Juan R López-Egido
Serena Fineschi
Nicolás Domínguez
Rufei Lu
Judith A James
Joan T Merrill
Jennifer A Kelly
Kenneth M Kaufman
Kathy L Moser
Gary Gilkeson
Johan Frostegård
Bernardo A Pons-Estel
Sandra D'Alfonso
Torsten Witte
José Luis Callejas
John B Harley
Patrick M Gaffney
Javier Martin
Joel M Guthridge
Marta E Alarcón-Riquelme
Oklahoma Medical Research Foundation · USUppsala University · SECentro Científico Tecnólogico - Rosario · ARCincinnati Children's Hospital Medical Center · USInstituto de Investigación Biosanitaria de Granada · ESInstituto de Parasitología y Biomedicina "López - Neyra" · ESKarolinska University Hospital · SELeibniz University Hannover · DEMedical University of South Carolina · USMerck Serono (Switzerland) · CHUnited States Department of Veterans Affairs · USUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

THE EFFECTS OF ERK PATHWAY INHIBITION ON DNA METHYLATION IN SLEP20RR015577 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI JAMES, JUDITH A · 2000 to 2009
$21.5M
VALIDATING NOVEL GENES IMPLICATED IN LEUKOCYTE CHEMOTAXISP20RR020143 · NCRR · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2004 to 2011
$21.0M
Program Project in the Genetics of SLEP01AR049084 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2002 to 2012
$12.7M
SequencingP01AI083194 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2009 to 2013
$9.6M
HLA GENE COMPLEMENTATION IN PRIMARY SJOGREN'S AND LUPUSR01AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KOTTYAN, LEAH CLAIRE, WEIRAUCH, MATTHEW TYSON · 1987 to 2025
$7.8M
SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
Pre-Clinical Studies to Identify SLE Therapeutic TargetsU19AI082714 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2009 to 2018
$6.2M
Patient Resource CoreP60AR062755 · NIAMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI KAMEN, DIANE L · 2012 to 2016
$5.8M
THROMBOCYTOPENIA AND THE GENETICS OF SEVERE LUPUSP50AR048940 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI REICHLIN, MORRIS · 2002 to 2006
$5.8M
GENETIC ASSOCIATION WITH LUPUS IN AMERICAN BLACKSR01AR042460 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 1993 to 2009
$5.1M
Molecular Mechanisms and Genetics of AutoimmunityP20GM103456 · NIGMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GAFFNEY, PATRICK M · 2012 to 2013
$4.8M
Genetic Linkage in LupusR37AI024717 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI HARLEY, JOHN BARKER · 2005 to 2014
$4.2M
NCRR NIH HHS P20 RR015577NCRR NIH HHS P20 RR020143NCRR NIH HHS RR015577NCRR NIH HHS RR020143NIAID NIH HHS AI031584NIAID NIH HHS AI063274NIAID NIH HHS AI082714NIAID NIH HHS AI083194NIAID NIH HHS AI24717NIAID NIH HHS N01 AI050026-001NIAID NIH HHS P01 AI083194NIAID NIH HHS R01 AI024717NIAID NIH HHS R01 AI031584NIAID NIH HHS R01 AI063274NIAID NIH HHS R37 AI024717NIAID NIH HHS R56 AI063274NIAID NIH HHS U19 AI082714NIAMS NIH HHS AR043247NIAMS NIH HHS AR048940NIAMS NIH HHS AR049084NIAMS NIH HHS AR052125NIAMS NIH HHS AR053483NIAMS NIH HHS AR42460NIAMS NIH HHS N01 AR062277NIAMS NIH HHS P01 AR049084NIAMS NIH HHS P30 AR053483NIAMS NIH HHS P50 AR048940NIAMS NIH HHS P60 AR062755NIAMS NIH HHS R01 AR042460NIAMS NIH HHS R01 AR052125NIDCR NIH HHS R01 DE018209NIGMS NIH HHS P20 GM103456NIGMS NIH HHS P30 GM103510
6 · The paper itself

Abstract

objectivesAltered signalling in B cells is a predominant feature of systemic lupus erythematosus (SLE). The genes BANK1 and BLK were recently described as associated with SLE. BANK1 codes for a B-cell-specific cytoplasmic protein involved in B-cell receptor signalling and BLK codes for an Src tyrosine kinase with important roles in B-cell development. To characterise the role of BANK1 and BLK in SLE, a genetic interaction analysis was performed hypothesising that genetic interactions could reveal functional pathways relevant to disease pathogenesis.

methodsThe GPAT16 method was used to analyse the gene-gene interactions of BANK1 and BLK. Confocal microscopy was used to investigate co-localisation, and immunoprecipitation was used to verify the physical interaction of BANK1 and BLK.

resultsEpistatic interactions between BANK1 and BLK polymorphisms associated with SLE were observed in a discovery set of 279 patients and 515 controls from northern Europe. A meta-analysis with 4399 European individuals confirmed the genetic interactions between BANK1 and BLK. As BANK1 was identified as a binding partner of the Src tyrosine kinase LYN, the possibility that BANK1 and BLK could also show a protein-protein interaction was tested. The co-immunoprecipitation and co-localisation of BLK and BANK1 were demonstrated. In a Daudi cell line and primary naive B cells endogenous binding was enhanced upon B-cell receptor stimulation using anti-IgM antibodies.

conclusionThis study shows a genetic interaction between BANK1 and BLK, and demonstrates that these molecules interact physically. The results have important consequences for the understanding of SLE and other autoimmune diseases and identify a potential new signalling pathway.

Indexed as

Adaptor Proteins, Signal TransducingB-LymphocytesCase-Control StudiesEpistasis, GeneticFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansLupus Erythematosus, SystemicMaleMembrane ProteinsPolymorphism, Single NucleotideProtein BindingSignal Transductionsrc-Family KinasesAdaptor Proteins, Signal TransducingBANK1 protein, humanMembrane Proteinsprotein-tyrosine kinase p55(blk)src-Family Kinases

Identifiers

PMID21978998
PMCPMC3268679
OpenAlexW1984533632

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.